One of the most relevant brands among our more than 25 partners is TargetMol
We have reached an agreement with TargetMol: CymitQuimica clients will benefit for a 20% discount on all TargetMol products until the end of the year.On our website you can find the products offered by this partner, which has become one of the world's most recognised compound libraries and small molecule inhibitors supplier. TargetMol offers approximately 120 compound libraries and a wide range of chemical products and kits for life sciences.
Ends on Dec 31( 7 days left )
Plasma kallikrein-IN-2
Plasma kallikrein-IN-2: PKal inhibitor, IC50=0.1 nM. Used in angioedema, diabetic eye disease research.Formula:C28H24ClF3N8O3Color and Shape:SolidMolecular weight:612.99KRAS G12C inhibitor 35
CAS:<p>KRAS G12C inhibitor 35 targets KRAS G12C in cancer research (CN112920183A, compound 3).</p>Formula:C31H27ClF2N6O3Color and Shape:SolidMolecular weight:605.035-Amino-2-chloropyridine
CAS:<p>5-Amino-2-chloropyridine is Pyridine intermediates</p>Formula:C5H5ClN2Purity:>99.99%Color and Shape:SoildMolecular weight:128.5600KRAS G12C inhibitor 37
CAS:KRAS G12C inhibitor 37 targets a key signaling protein, showing promise for cancer research involving KRAS G12C.Formula:C35H39F3N8O2Color and Shape:SolidMolecular weight:660.73KRAS G12C inhibitor 39
CAS:KRAS G12C inhibitor 39 effectively targets KRAS G12C, a key protein in cancer research.Formula:C37H43N9O2Color and Shape:SolidMolecular weight:645.8KRAS G12C inhibitor 40
CAS:KRAS G12C inhibitor 40 targets KRAS G12C in cancer research (WO2021129824A1, compound 70).Formula:C34H36ClFN10O2Color and Shape:SolidMolecular weight:671.17KRAS G12C inhibitor 41
CAS:<p>KRAS G12C inhibitor 41 targets a key signaling protein, potentially aiding cancer research.</p>Formula:C36H37ClFN9O2Color and Shape:SolidMolecular weight:682.19KRAS G12D inhibitor 10
CAS:KRAS G12D inhibitor 10 targets KRAS G12D in cancer research (WO2021108683A1, compound 34).Formula:C33H41ClN8O2Color and Shape:SolidMolecular weight:617.18KRAS G12C inhibitor 20
CAS:<p>KRAS G12C inhibitor 20 is a KRAS G12C inhibitor.</p>Formula:C33H37ClFN7O3Color and Shape:SolidMolecular weight:634.14KRAS G12C inhibitor 48
KRAS G12C inhibitor 48: potent with IC50 639.91 nM; hampers H358, H23, A549 cell growth with IC50s of 0.796, 6.33, 16.14 µM, respectively.Formula:C36H39ClN8O2Color and Shape:SolidMolecular weight:651.2Antibacterial agent 91
Antibacterial 91: Inhibits aaRS, IC50 2.10μM vs. S. enterica ThrRS, has antibacterial properties. [1]Formula:C33H31BrClN5O4Color and Shape:SolidMolecular weight:676.99D(+)-Phenylalaninol
CAS:<p>D(+)-Phenylalaninol is commonly used as a chiral reagent and a pharmaceutical intermediate.</p>Formula:C9H13NOPurity:95.69%Color and Shape:White To Light Yellow Crystal PowdeMolecular weight:151.21Antibacterial agent 92
Antibacterial agent 92 inhibits Salmonella's aaRS; IC50 of 0.58 μM for Se ThrRS. Exhibits antibacterial effects.Formula:C30H28Cl2F3N5O4Color and Shape:SolidMolecular weight:650.48Antibacterial agent 93
Antibacterial agent 93: potent aaRS inhibitor; effective against certain gram-positive and negative bacteria.Formula:C29H28Cl3N5O4Color and Shape:SolidMolecular weight:616.92KRAS G12D inhibitor 16
CAS:<p>KRAS G12D inhibitor 16 targets KRAS G12D with IC50 of 0.7 nM and mutant form at 0.35 μM, useful in various cancer studies.</p>Formula:C32H39IN6O3Color and Shape:SolidMolecular weight:682.59KRAS G12C inhibitor 56
CAS:KRAS G12C inhibitor 56, a powerful inhibitor of SOS1 with an inhibitory concentration (IC50) of 1.6 nM, holds promise for use in cancer research.Formula:C32H39N7O4SColor and Shape:SolidMolecular weight:617.76Antimicrobial agent-14
CAS:Antimicrobial agent-14, a benzyl thiophene sulfonamide, has a 200 μM MIC against Campylobacter coli ATCC33559.Formula:C9H8ClNO3S2Purity:99.02%Color and Shape:SolidMolecular weight:277.75Menin-MLL inhibitor 26
CAS:Menin-MLL inhibitor 26: Active reference, inhibits cell growth, used in leukemia research.Formula:C27H29F3N6O3SColor and Shape:SolidMolecular weight:574.62Antiangiogenic agent 3
Antiangiogenic agent 3 blocks HUVEC cell migration, chemotaxis, and lowers Src, cdc42, MAPK gene expression.Formula:C19H20O7Color and Shape:SolidMolecular weight:360.36SARS-CoV-2 3CLpro-IN-5
CAS:SARS-CoV-2 3CLpro-IN-5 is a covalent inhibitor targeting the 3C-like protease (3CLpro), exhibiting potent inhibitory activity with an IC50 of 3.8 nM andFormula:C22H26ClF2N5O4Purity:98%Color and Shape:SolidMolecular weight:497.92SARS-CoV-2 3CLpro-IN-6
CAS:SARS-CoV-2 3CLpro-IN-6: reversible inhibitor for COVID-19 3CL protease, IC50 4.9 μM, useful in research.Formula:C22H15NO7Color and Shape:SolidMolecular weight:405.36SARS-CoV-2 3CLpro-IN-7
CAS:SARS-CoV-2 3CLpro-IN-7 is a reversible covalent inhibitor of the SARS-CoV-2 3CL protease, exhibiting an inhibitory concentration (IC50) value of 1.4 µM.Formula:C24H17ClN2O6Color and Shape:SolidMolecular weight:464.85Neuroinflammatory-IN-3
CAS:Neuroinflammatory-IN-3 is a potent tubulin inhibitor with anti-neuroinflammatory and antitumor properties.Formula:C19H19ClO3Color and Shape:SolidMolecular weight:330.81PI3K/mTOR Inhibitor-12
CAS:PI3K/mTOR Inhibitor-12: oral, potent, selective; IC50: PI3Kα 0.06 nM, mTOR 3.12 nM; strong antitumor; less liver toxicity.Formula:C27H27F2N9O4SPurity:98%Color and Shape:SolidMolecular weight:611.62Mifanertinib dimaleate
CAS:<p>Mifanertinib dimaleate is a potent tyrosine kinase inhibitor with antineoplastic activity .</p>Formula:C29H27ClF3N5O10Color and Shape:SolidMolecular weight:6982-Acetamidophenol
CAS:<p>2-Acetamidophenol (Orthocetamol) has analgesic and antipyretic effects. 2-Acetamidophenol is an isomer of Paracetamol (4-acetamidophenol).</p>Formula:C8H9NO2Purity:>99.99%Color and Shape:Light Brown PowderMolecular weight:151.16PI3K/mTOR Inhibitor-13
CAS:PI3K/mTOR Inhibitor-13, an oral dual blocker of PI3K and mTOR, may treat sexual diseases, solid tumors, and IPF.Formula:C20H13F2N5O3SColor and Shape:SolidMolecular weight:441.41Dihydro-β-erythroidine
CAS:Dihydro-β-erythroidine, a competitive nicotinic receptor antagonist, effectively blocks the discriminative stimulus properties and inhibits the anxiolyticFormula:C16H21NO3Color and Shape:SolidMolecular weight:275.343,3-Dimethyl-1-butanol
CAS:3,3-Dimethyl-1-butanol (DMB) inhibits TMA/TMAO and affects p65 NF-κB, TGF-β1/Smad3 signaling; potential for CVD treatment.Formula:C6H14OColor and Shape:SolidMolecular weight:102.17(S)-LY3177833 hydrate
CAS:(S)-LY3177833 ((S)-Example 2) hydrate, an orally active CDC7 kinase inhibitor, exhibits extensive in vitro anticancer efficacy.Formula:C16H14FN5O2Color and Shape:SolidMolecular weight:327.31LDC4297 hydrochloride
CAS:LDC4297 hydrochloride is a selective and potent CDK7 inhibitor with broad-spectrum antiviral activity, useful for research on viral infections.Formula:C23H29ClN8OColor and Shape:SolidMolecular weight:468.98MRL-494 hydrochloride
MRL-494 HCl: β-barrel assembly inhibitor, combats Gram+ & Gram- bacteria, MICs: 12.5μM S. aureus, 25μM E. coli.Formula:C26H36ClFN16O2Color and Shape:SolidMolecular weight:659.12CBB1007 hydrochloride
CAS:CBB1007 Hcl inhibits LSD1 selectively (IC50=5.27μM), blocks H3K4 demethylation, activates genes; less effect on other cells/tissues.Formula:C27H39Cl5N8O4Color and Shape:SoildMolecular weight:716.91Estradiol hemihydrate
CAS:Estradiol hemihydrate: major female hormone, boosts neural differentiation, studied for cancer and neurodegenerative disease.Formula:C18H26O3Color and Shape:SolidMolecular weight:281.39Clocortolone pivalate
CAS:Clocortolone pivalate, a synthetic steroid, treats dermatitis and psoriasis.Formula:C27H36ClFO5Color and Shape:SolidMolecular weight:495.02E7766 diammonium salt
CAS:<p>E7766 diammonium salt, a macrocycle-bridged STING agonist, exhibits a dissociation constant (Kd) of 40 nM, demonstrating potent pan-genotypic and antitumor</p>Formula:C24H32F2N12O8P2S2Color and Shape:SolidMolecular weight:780.66Crozbaciclib fumarate
CAS:Crozbaciclib fumarate is a CDK4/6 inhibitor with IC 50 s of 3 and 1 nM, respectively.Formula:C32H34F2N6O4Color and Shape:SolidMolecular weight:604.65KRAS G12D inhibitor 3
CAS:KRAS G12D Inhibitor 3, a compound targeting the KRAS G12D mutation, demonstrates potent antitumor efficacy with an inhibitory concentration (IC50) of less thanFormula:C34H31ClF3N5O2Color and Shape:SolidMolecular weight:634.09CB1 inverse agonist 2
CAS:CB1 inverse agonist 2, an oral drug, counters CB1 effects, reducing CP55940-induced hypothermia and anorexia in mice.Formula:C24H20ClFN2OSColor and Shape:SolidMolecular weight:438.94Antimalarial agent 20
CAS:Antimalarial agent 20, exhibiting potent efficacy with an IC50 value of 0.6 nM against the P.Formula:C31H38N4O3Color and Shape:SolidMolecular weight:514.66PARP11 inhibitor ITK7
CAS:ITK7 is a potent, selective PARP11 inhibitor with an IC50 of 14 nM, useful for cellular localization research.Formula:C17H14N4OSColor and Shape:SolidMolecular weight:322.38LIMK1 inhibitor BMS-4
CAS:BMS-4 is a LIMK inhibitor targeting LIMK1/2, reduces cofilin phosphorylation, noncytotoxic to A549 cells.Formula:C23H23N7O2SColor and Shape:SolidMolecular weight:461.54Ferroptosis inducer-1
CAS:Ferroptosis inducer-1 is a Ferroptosis inducer with antitumor potential .Formula:C25H21ClN2O5Color and Shape:SolidMolecular weight:464.95-Cyclopropylpentanal
CAS:5-Cyclopropylpentanal, an olfactory receptor agonist, effectively enhances OR-I7 activation, demonstrating an EC50 value of 0.3 μM.Formula:C8H14OColor and Shape:SolidMolecular weight:126.2Tofacitinib Prodrug-1
Tofacitinib Prodrug-1: an oral prodrug reducing Tofacitinib's side effects, treats ulcerative colitis in mice effectively with low toxicity.Formula:C36H39ClN10O7Color and Shape:SolidMolecular weight:759.21c-Met/MEK1/Flt-3-IN-1
Antiproliferative Against-3 (comp 33) demonstrates significant activity against Hela (IC 50 = 0.21 µM), A549 (IC 50 = 0.39 µM), and MCF-7 (IC 50 = 0.33 µM) cellFormula:C39H37FN6O5Color and Shape:SolidMolecular weight:688.75PI3K/mTOR Inhibitor-5
CAS:PI3K/mTOR Inhibitor-5 is a potent dual inhibitor of PI3K and mTOR, displaying IC50 values of 86.9 nM (for PI3K) and 14.6 nM (for mTOR), respectively.Formula:C32H40N10O3Color and Shape:SolidMolecular weight:612.73Xanthine oxidase-IN-6
Xanthine oxidase-IN-6: potent oral mixed-type XOD inhibitor, IC50 1.37 µM, anti-hyperuricemia, renal protection.Formula:C29H34N2O15Color and Shape:SolidMolecular weight:650.58Sortilin antagonist 1
CAS:Sortilin antagonist 1 blocks Neurotensin binding with 20 nM IC50, useful in neurological disease research.Formula:C20H24N2O4Color and Shape:SolidMolecular weight:356.42Kobusine derivative-2
Kobusine derivative-2 halts MDA-MB-231 cancer cell growth in sub-G1 phase.Formula:C36H35Cl4NO4Color and Shape:SolidMolecular weight:687.48Antimicrobial agent-5
<p>Antimicrobial agent-5: potent, selective for Gram-negative/positive bacteria, blocks LPS-CD14/TLR4, anti-inflammatory.</p>Formula:C32H48N16Color and Shape:SolidMolecular weight:656.83Antimicrobial agent-6
Antimicrobial agent-6: MIC 4-8 μg/mL for gram+ & gram- bacteria, anti-inflammatory.Formula:C40H64N16Color and Shape:SolidMolecular weight:769.04Antimicrobial agent-8
Antimicrobial agent-8: potent against Gram+ & Gram-, 2-8 μg/mL MIC, anti-inflammatory action.Formula:C39H54N16Color and Shape:SolidMolecular weight:746.95Antimalarial agent 18
Potent antimalarial, lipophilic, inhibits P. falciparum (IC50=50nM) & A. baumanii (IC50=390nM), blocks non-mevalonate pathway.Formula:C23H44NO9PColor and Shape:SolidMolecular weight:509.57AChE/Nrf2 modulator 1
CAS:AChE/Nrf2 modulator 1: oral, targets AChE/Nrf2, IC50s: 0.07 μM (eeAChE), 0.38 μM (hAChE); for Alzheimer's research.Formula:C27H27FN4O2Color and Shape:SolidMolecular weight:458.53MTK458
CAS:<p>MTK458 (EP-0035985) is a PINK1 activator with antidepressant activity for the study of Parkinson;s disease.</p>Formula:C17H15F3N4Purity:98.36%Color and Shape:SolidMolecular weight:332.32LRRK2/NUAK1/TYK2-IN-1
CAS:LRRK2/NUAK1/TYK2-IN-1 inhibits LRRK2, TYK2, NUAK1 with IC50 < 10 nM, useful in autoimmune research.Formula:C20H11F3N6Color and Shape:SolidMolecular weight:392.34Endomorphin 1 acetate
CAS:Endomorphin 1 acetate is a μ-opioid receptor agonist with antinociceptive and analgesic effects and can be used to study neurological diseases.Formula:C36H42N6O7Purity:99.74%Color and Shape:SolidMolecular weight:670.75α-Lipoic Acid sodium
CAS:α-Lipoic Acid sodium (Thioctic acid sodium) is an antioxidant and cofactor for mitochondrial enzyme complexes. It inhibits NF-κB-dependent HIV-1 replication.Formula:C8H13NaO2S2Purity:99.68%Color and Shape:SolidMolecular weight:228.31L-Kynurenine sulfate
CAS:L-Kynurenine sulfate activates AHR, leading naive T cells to anti-inflammatory Treg phenotype.Formula:C10H14N2O7SColor and Shape:SolidMolecular weight:306.29Theliatinib tartrate
CAS:Theliatinib: oral EGFR blocker, Ki 0.05 nM, IC50 3 nM (wild-type), 22 nM (T790M/L858R), >50x kinase selectivity.Formula:C29H32N6O8Color and Shape:SolidMolecular weight:592.6Cimpuciclib tosylate
CAS:Cimpuciclib tosylate, a selective CDK4 inhibitor (IC50: 0.49 nM), exhibits anti-tumor activity.Formula:C37H43FN8O4SColor and Shape:SolidMolecular weight:714.85cis,trans-Germacrone
CAS:<p>cis,trans-Germacrone is an antitumor, antioxidant isomer that inhibits lung cancer and affects Akt/MDM2/p53.</p>Formula:C15H22OColor and Shape:SolidMolecular weight:218.33PARP1/2/TNKS1/2-IN-1
CAS:PARP1/2/TNKS1/2-IN-1 is a multi-target inhibitor of PARP-1, PARP-2, TNKS1 and TNKS2.PARP1/2/TNKS1/2-IN-1 has anti-tumor activity and induces apoptosis.Formula:C35H31FN6O5Purity:99.63%Color and Shape:SolidMolecular weight:634.66Calpain Inhibitor XI
CAS:Calpain Inhibitor XI, a reversible covalent inhibitor of calpain-1, is utilized in the research of neurodegenerative disorders.Formula:C26H40N4O6Color and Shape:SolidMolecular weight:504.62Anticancer agent 100
CAS:<p>Anticancer agent 100, a tetracaine derivative, exhibits anti-cancer activity and is applied in cancer research.</p>Formula:C18H20ClN3OColor and Shape:SolidMolecular weight:329.82Tubulin inhibitor 30
CAS:Tubulin Inhibitor 30, exhibiting an IC50 value of 0.52 μM, functions as an inhibitor of tubulin assembly. Additionally, it can induce ferroptosis.Formula:C22H19N3O5Color and Shape:SolidMolecular weight:405.4SARS-CoV-2 Mpro-IN-4
SARS-CoV-2 Mpro-IN-4 inhibits Mpro (IC50: 900 nM) & CatL (IC50: 60 nM), blocks virus replication (IC50: 8.2 nM).Formula:C30H38N4O5Color and Shape:SolidMolecular weight:534.65SARS-CoV-2 Mpro-IN-5
<p>SARS-CoV-2 Mpro-IN-5: inhibits Mpro (IC50=1800nM) & CatL (IC50=145nM), antiviral, hinders replication in hACE2 A549 cells (IC50=14.7nM).</p>Formula:C34H43FN4O7Color and Shape:SolidMolecular weight:638.73Thrombin inhibitor 6
CAS:Thrombin Inhibitor 6, with an IC 50 of 1 nM, acts as a potent anticoagulant by inhibiting thrombin.Formula:C18H19ClN4O2SColor and Shape:SolidMolecular weight:390.89Tubulin inhibitor 31
Tubulin inhibitor 31: potent with 4 µM IC50, anti-proliferative, inhibits HUVEC migration.Formula:C22H19NO2Color and Shape:SolidMolecular weight:329.39Influenza virus-IN-6
CAS:Influenza virus-IN-6 (Compound 35) serves as a potent inhibitor targeting the N-terminal domain of the polymerase acidic protein (PA N ) endonuclease subunit ofFormula:C27H26ClNO7Purity:98%Color and Shape:SolidMolecular weight:511.95SARS-CoV-2 Mpro-IN-6
CAS:SARS-CoV-2 Mpro-IN-6: irreversible Mpro inhibitor, IC50 0.18 μM, selective; doesn't block cathepsins B/F/K/L or caspase 3.Formula:C18H18Cl3N3O2SColor and Shape:SolidMolecular weight:446.78AChE/BChE/MAO-B-IN-2
AChE/BChE/MAO-B-IN-2 inhibits AChE (48.2 nM), BChE (83.9 nM), MAO-B (31.2 nM), has antioxidant activity, and aids Parkinson's research.Formula:C25H31N3O3Color and Shape:SolidMolecular weight:421.53AChE/BChE/MAO-B-IN-3
<p>AChE/BChE/MAO-B-IN-3: potent MAO-B, AChE & BChE inhibitor; IC50: 0.0359μM (MAO-B), 0.0473/0.0782μM (AChE/BChE); possible Alzheimer's research use.</p>Formula:C25H31N3O3Color and Shape:SolidMolecular weight:421.53AChE/BChE/MAO-B-IN-4
AChE/BChE/MAO-B-IN-4 inhibits MAO-B (IC50: 0.0393 µM), AChE (IC50: 0.0458 µM), BChE (IC50: 0.075 µM), and fights AD with antioxidant action.Formula:C26H33N3O4Color and Shape:SolidMolecular weight:451.563-Oxo-hop-22(29)-ene
CAS:3-Oxo-hop-22(29)-ene inhibits yeast α-glucosidase, moderately affects T. cruzi and L. mexicana, and has slight anti-inflammatory activity.Formula:C30H48OColor and Shape:SolidMolecular weight:424.7EFdA-TP tetrasodium
CAS:EFdA-TP tetrasodium is a potent HIV-1 inhibitor that blocks DNA synthesis as an ICT or DCT.Formula:C12H11FN5Na4O12P3Purity:98%Color and Shape:SolidMolecular weight:621.12(2S,5S)-Censavudine
<p>(2S,5S)-Censavudine, a potent HIV inhibitor and nucleoside reverse transcriptase blocker.</p>Formula:C12H12N2O4Color and Shape:SolidMolecular weight:248.23Umbralisib tosylate
CAS:Umbralisib tosylate, an oral PI3Kδ/CK1ε inhibitor (EC50: 22.2 nM/6.0 μM), shows promise for CLL research.Formula:C38H32F3N5O6SColor and Shape:SolidMolecular weight:743.755-Iminodaunorubicin
CAS:5-Iminodaunorubicin: a quinone-altered anthracycline with antitumor effects, causing DNA breaks in cancer.Formula:C27H30N2O9Color and Shape:SolidMolecular weight:526.54Anticancer agent 25
CAS:Anticancer agent 25 demonstrates the highest level of cytotoxic effectiveness on PC3 cells, achieving an IC 50 value of 0.19 μM.Formula:C37H45BrN2O3Color and Shape:SolidMolecular weight:645.67Estrone O-sulfamate
CAS:<p>Estrone 3-O-sulfamate, a strong STS inhibitor with IC50 of 18 nM in placenta and 0.83 nM in MCF-7 cells, is used in cancer research.</p>Formula:C18H23NO4SPurity:99.86%Color and Shape:SolidMolecular weight:349.44Antioxidant agent-2
CAS:Antioxidant agent-2 (3c), BBB-permeable, selectively chelates metals; shows neuroprotection, fights liver damage in Alzheimer's research.Formula:C23H26N2O7Color and Shape:SolidMolecular weight:442.46NOD1/2 antagonist-1
CAS:<p>NOD1/2 antagonist-1 inhibits NOD1 (IC50 1.13 μM) and NOD2 (IC50 0.77 μM), enhances paclitaxel antitumor efficacy and is used to study innate immune signaling.</p>Formula:C32H28ClF5N4O4Purity:99.69%Color and Shape:SolidMolecular weight:663.03Anticancer agent 53
CAS:Anticancer agent 53 exhibits potent in vitro cytotoxicity, triggers apoptosis, halts S/G2/M cycle, and has antitumor effects without toxicity.Formula:C31H25FN4O6SColor and Shape:SolidMolecular weight:600.62Anticancer agent 58
Anticancer agent 58 targets A549/T24 cell lines; IC50: 0.6/0.7 μM. It triggers apoptosis, ups Ca2+/ROS, and lowers mitochondrial potential.Formula:C39H55NO5Color and Shape:SolidMolecular weight:617.86Anticancer agent 59
Anticancer agent 59 suppresses various cancers, notably A549 at IC50 of 0.2 μM, induces apoptosis and disrupts mitochondria in mice.Formula:C42H59NO6Color and Shape:SolidMolecular weight:673.92Anticancer agent 66
CAS:<p>Anticancer agent 66, a ciprofloxacin analog, triggers apoptosis in MCF-7 cells.</p>Formula:C26H23Cl2FN6O2S2Color and Shape:SolidMolecular weight:605.53Dazostinag disodium
CAS:<p>Dazostinag disodium (TAK-676) is a synthetic novel interferon gene (STING) agonist.Cost-effective and quality-assured.</p>Formula:C21H20F2N8Na2O10P2S2Purity:98.84% - 99.96%Color and Shape:SolidMolecular weight:754.48Sirtuin modulator 4
CAS:Sirtuin modulator 4 inhibits SIRT1 (EC50: 51-100 μM), may extend cell life and prevent diseases like diabetes and cancer.Formula:C18H10N2O2SColor and Shape:SolidMolecular weight:318.35SIRT6 activator 12q
CAS:SIRT6 activator 12q: potent, selective, oral; IC50 - SIRT1: 171.20μM, SIRT6: 0.58μM; halts cell growth/migration, induces apoptosis, G2 arrest, anticancer.Formula:C31H22N2O2Color and Shape:SolidMolecular weight:454.52Anticancer agent 99
CAS:Anticancer agent 99 targets HepG2 cells, IC50 at 35.9 μM, induces apoptosis and hinders cell growth.Formula:C19H20F3N3O2Color and Shape:SolidMolecular weight:379.38GnRH-R antagonist 1
CAS:Compound 21a: Oral GnRH-R antagonist, IC50=0.57 nM, potent against prostate cancer/prevents LH surges.Formula:C31H28F5N7O6SPurity:98%Color and Shape:SolidMolecular weight:721.65CYP4A11/CYP4F2-IN-1
CAS:CYP4A11/CYP4F2-IN-1 is a cytochrome P450 (CYP) 4A11 and CYP4F2 inhibitor for the study of kidney disease and cardiovascular disease.Formula:C15H15N3OSPurity:99.75%Color and Shape:SolidMolecular weight:285.36Anticancer agent 92
Anticancer agent 92 is an anticancer agent that is nontoxic against noncancerous cells .Formula:C21H23ClN4O3SColor and Shape:SolidMolecular weight:446.95Antitubulin agent 1
Antitubulin agents-1 disrupts microtubules, ups α-tubulin acetylation, and has anticancer properties.Formula:C21H19N3O3Color and Shape:SolidMolecular weight:361.39Aurora Kinases-IN-3
CAS:Aurora Kinases-IN-3 is an oral AURKB inhibitor that disrupts its mitotic localization, not its H3 Ser10 phosphorylation.Formula:C20H16F3N3O4Color and Shape:SolidMolecular weight:419.35CTP Synthetase-IN-1
CAS:CTP Synthetase-IN-1 is a cytidine 5'-triphosphate synthetase (CTPS) inhibitor with antitumor activity for the study of arthritis and rheumatoid arthritis.Formula:C20H19F3N6O3S2Purity:98.11% - 99.18%Color and Shape:SolidMolecular weight:512.53CTP Synthetase-IN-1 Ammonium salt
<p>CTP Synthetase-IN-1 Ammonium salt is a CTPS inhibitor with potential antibacterial, anti-inflammatory, and antitumor activity for the study of SARS-CoV-2 viral infections</p>Formula:C20H22F3N7O3S2Purity:99.97%Color and Shape:SolidMolecular weight:529.56
